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ABSTRACT 
Objective: The goal of this preliminary work was to observe the impact of the prolonged reduced-pressure condition prior to labeling stage on the 
F-18 Fluorocholine labeling yield at the end of synthesis. 
Methods: At this present work, the condition inside the reactor vial prior to labeling stage was manipulated. In the first technique of syntheses of F-
18 Fluorocholine, the condition inside the reactor vial was set at 0 atmospheric pressure (0 atm) while in the second technique the condition inside 
the reactor was set at reduced-pressure (between-0.65 to-0.85 bars) with the delay time of 120 seconds. At the end of the synthesis, the impact of 
the prolonged reduced-pressure condition prior to precursor labeling was measured in terms of labeling yield of F-18 Fluorocholine.  
Results: With the second technique, the labeling yield of F-18 Fluorocholine was elevated from 9.7% (the first technique) to 24.3%. 
Conclusion: This preliminary work indicates that delay in a reduced-pressure condition prior to labeling step has greatly improved the labeling 
yield of F-18 Fluorocholine at the end of synthesis. Using this approach, the labeling yield of F-18 Fluorocholine was elevated from 7.5% to 24.3%. 
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N-methyl-(C-11) choline (C-11 choline) was the first choline derivative 
labeled with positron emitter isotopes [1]. Since then, C-11 choline 
proved to be an effective marker in various tumors located in brain, 
lungs, urinary bladder, and most significantly in prostate [1-5]. However, 
due to the short half-life of radioisotope carbon-11 compared to 
radioisotope fluorine-18, it becomes a limiting factor to those centres 
which are not cyclotron-bounded. For this reason, fluorinated labeled 
choline, N,N-dimethyl-N-(F-18)-fluoromethyl-2-hydroxyethyl ammonium 
or known as F-18 Fluorocholine, has been developed as a substitute for 
choline derivatives in Positron Emission Tomography (PET) imaging 
technique [6-8]. Due to its high positron emission abundance, low 
positron energy, the small ion radius and its ease of production, fluorine-
18 (F-18) become the most extensively used radioisotope for PET 
imaging technique. In addition, the half-life of fluorine-18 is relatively 
long enough to allow for multistep synthesis and transportation to 
remote hospitals without an on-site cyclotron [9-10].  
In 2001, DeGrado had successfully synthesised F-18 Fluorocholine 
using the reactive intermediate, F-18 fluorobromomethane (F-18 
CH2Br) [11-13]. DeGrado’s work was followed by Iwata in 2002 
but using F-18 fluoromethyl triflate, a different reactive 
intermediate [14]. In 2008, Kryza and co-workers had successfully 
synthesised F-18 Fluorocholine using a similar approach as 
DeGrado but eliminated the use of semi-preparative HPLC column 
for purification [15].  
In this attempt, F-18 Fluorocholine were synthesised in accordance 
with Kryza method on an automated synthesis platform, GE 
TracerLab MXFDG [15]. It is known the limiting factor that affects the 
F-18 Fluorocholine production around the globe, is due to its 
relatively low yield. Therefore, this preliminary works attempt to 
investigate whether a prolonged reduced-pressure condition prior 
to labeling step will affect the yield of F-18 Fluorocholine. 
  
 
Fig. 1: Synthesis of F-18 fluorocholine 
 
At the present works, two techniques were employed to observe 
the impact of the prolonged reduced-pressure condition on the 
yield of F-18 Fluorocholine. In the first technique, during the 
syntheses of F-18 Fluorocholine (n = 3), succeeding to F-18 ions 
elution to reactor vial, the condition inside the reactor was set at 0 
atmospheric pressure (0 atm). Meanwhile, in the second 
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technique, the condition inside the reactor was set at reduced 
pressure (between-0.65 to-0.85 bars) with 120 seconds of 
additional time. 
The synthesis time for F-18 Fluorocholine was 50±5 min. The 
labeling yield of F-18 Fluorocholine at the end of synthesis for both 
techniques was found to be significantly different (table 1). 
 
Table 1: Overview of F-18 fluorocholine RCY (%) 
Synthesis (Technique) 1 2 3 
1st technique 7.5 9.1 9.7 
2nd technique 19.8 19.8 24.3 
For Technique 1, the highest labeling yield was only 9.7% (decay not corrected) and was found to be lower than the average labeling yield for Group 
2, 21.3%. 
 
In most of the published works, the F-18 Fluorocholine had a 
relatively low yield, between 5 to 15%. It was acknowledged that the 
yield of F-18 Fluorocholine is not largely dependent upon the initial 
amount of fluorine-18 activity transferred from cyclotron [15]. 
Nevertheless, the yield relied upon the fluorination conditions of 
dibromomethane [15]. However, the amount of dibromomethane 
added into the reactor did not certainly increase the yield as similar 
yield was noticed when the amounts of dibromomethane used 
varied from 200 to 400 µl [15].  
At the present work, the highest yield for F-18 Fluorocholine when 
the reactor at 0 atm was only 9.7%. Though it was still within the 
range of 5 to 10% in most of the studies, the labeling yield has been 
greatly improved when the conditions inside the reactor prior to 
labeling stage was set at reduced-pressure with an additional time of 
120 seconds. The F-18 Fluorocholine yield was elevated at 24.3%. 
When the conditions inside the reactor vial prior to labeling stage 
was set at a reduced-pressure (-0.65 to-0.85 bars) with an additional 
time of 120 seconds, there was a possibility that prolonged 
azeotropic drying condition led to F-18 ions to be properly dried and 
allowed for removal of excessive water in form of residues that 
might possibly still present in acetonitrile solution even after 
successive azeotropic drying cycles. As a result, only the very 
reactive F-18 ions in evaporated acetonitrile were left inside the 
reactor prior to precursor labeling. 
  
 
Fig. 2: Percentage of labeling yield of F-18 fluorocholine 
 
In a work presented by Lasne on 2002 and later was supported by 
Cai on 2008, both agreed that in the presence of water although in 
the form of residue will make the F-18 ions are highly solvated and 
hydrogen bonded [16-17]. This, in turn, decreases the 
nucleophilicity of F-18 ions and making it unreactive [16-17]. Thus, 
it shows that prolonged reduced-pressure prior to labeling of 
dibromomethane with F-18 ions greatly affect the labeling yield of F-
18 Fluorocholine. Using this approach, the labeling yield of F-18 
Fluorocholine was elevated from 7.5% to 24.3%. However, 
additional work is needed to understand whether this technique is 
applicable to other F-18 radiolabeling syntheses.  
Limitations of the study 
As the F-18 Fluorocholine in this preliminary work was syntheses in 
limited number, hence the extent of the present work may be 
conducted on a large scale and also to include the quality control 
analysis, particularly the radiochemical purity analysis. 
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